Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, ...

The FDA reveals that phenylephrine, a popular decongestant, is no better than a placebo. Discover what this means for your ...

Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...

Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...

Decongestants (oral or nasal) Nasal steroid sprays, such as Nasonex (mometasone furoate monohydrate) or Flonase (fluticasone propionate) Decongestants and steroids are not appropriate for all people ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato ... was first approved in 2019 to be used in combination with antidepressants, and later ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...